Critical Path Institute is offering an exciting new opportunity for 
pharmacometricians. A new consortium focusing on quantitative drug development 
platforms for Huntington's disease is looking for a talented modeling and 
simulation scientist. This represents a great opportunity for intellectual and 
personal growth with a positive impact on public health, in a collaborative 
effort that allows the opportunity to interact with leading academics, industry 
scientists, and regulators. For more information, please check
 or contact

Daniela J Conrado, MS PhD
Associate Director, Quantitative Medicine
Critical Path Institute

Reply via email to